The fight against antimicrobial resistance: progress and challenges

  18 November 2023

Antimicrobial resistance (AMR) – when microbes evolve to resist the medicines designed to kill them – is an urgent global threat. In England, resistant infections rose by 4% in 2022 after decreasing during the pandemic. Action is needed to curb inappropriate antibiotic use, a key driver of resistance.

In 2013, we set up the English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) to collect data on the use of, and resistance to, these medicines. The 10th edition of the ESPAUR report, covering 2022 to 2023 has just been published.

In this post we highlight some of the progress and challenges reported.

 

Further reading: UK Health Security Agency
Author(s): UK Health Security Agency
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed